Physician profile
Allen Smith
NPI 1609911619
$1,357.83
in general payments reported to CMS, 2019-2025
15 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $690 · 2023: $162 · 2024: $138 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $216.01 | 2022-2023 | Wakix |
| Inari Medical, INC. | $200.98 | 2022 | |
| Boston Scientific Corporation | $137.82 | 2024 | Watchman Flx |
| Pulmonx Corporation | $129.11 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Intuitive Surgical, INC. | $117.97 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.38 | 2022 | |
| Ethicon US, LLC | $104.43 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $103.60 | 2022 | |
| Atricure, INC. | $101.15 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $38.04 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $35.69 | 2023 | Dupixent |
| Epizyme, INC. | $21.61 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.77 | 2022 | |
| Ethicon INC. | $15.06 | 2021 | |
| Chiesi USA, INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.